Current Edition

Upcoming Events

Advertisement

Volume 6 Issue 1

Are Nitrosamines a Concern for Biologic Manufacturers?

The discovery of nitrosamine genotoxins in several pharmaceuticals has led to monitoring and re-evaluation of manufacturing practices for those products considered a...
Continue Reading →
Volume 6 Issue 1

Global Sterile Manufacturing and Lyophilization Capabilities of Large and Small Molecule Biologics – PCI Shows the Way

PCI’s global manufacturing capabilities are in complex formulations, high potency, and lyophilization and your capabilities cover a broad range of injectables includi...
Continue Reading →
Volume 6 Issue 1

High Accuracy Flow Meter for Low Flow Measurements

With the growing popularity of micro-bioreactors, perfusion, as well as cell & gene therapy applications in the life sciences industry, the need to measure low fl...
Continue Reading →
Volume 6 Issue 1

Generating Powerful New Pharma Insights from Graphs

Neo4j’s Alex Jarasch explains how knowledge graphs can be a valuable asset for the pharmaceutical industry to extract insights from complex data. An interesting poss...
Continue Reading →
Volume 6 Issue 1

Causal Inference and the Future of Clinical Trials

Randomizing every non-essential variable in a scientific experiment to isolate only specific relations is the simple but powerful idea behind Randomized Controlled Tr...
Continue Reading →
Volume 6 Issue 1

The Future of the Connected Drug Delivery Device Market: Key Areas for Innovation

The past two decades have seen huge growth in the market for injectable drug delivery products; this shows little sign of slowing down with a further 9.1% of annual g...
Continue Reading →
Volume 6 Issue 1

The Opportunities and Obstacles of Filling and Packaging Pre-filled Syringes

Pre-filled syringes (PFS) offer plenty of advantages for injectable drug formulations, but also have challenges ranging from sterile integrity requirements to packagi...
Continue Reading →
Volume 6 Issue 1

Are Nitrosamines a Concern for Biologic Manufacturers?

First described over a century ago, the class of organics known as N-nitrosamines are defined by the common structural feature, R2NNO. Since the mid-1950s when their ...
Continue Reading →
Volume 6 Issue 1

Analytical Method Release and Stability Platform for RNA Drug Substance

As a leader in cell and gene therapy (CGT) manufacturing and testing for 25 years, Aldevron has built superior analytical capabilities and expertise to support charac...
Continue Reading →
Volume 6 Issue 1

Beyond Symptom Relief: Human iPSC-derived Models for the Development of Life-changing Therapies for Neurodegenerative Diseases

The complexity and epidemiology of neurodegenerative diseases demands the incorporation of alternative approaches for the development of disease-modifying therapies t...
Continue Reading →